Strengthening Drug Supply Chains: CDMO Strategies for Stability

Drug supply chains are facing increasing risks from geopolitical and environmental disorders. CDMO plays an important role in ensuring medical supply stability by using flexible strategies. As the industry develops, small-molecule CDMOs should embrace innovation and agility to balance supply and demand, promote progress, and improve the patient results in a dynamic landscape.

https://www.pharmafocusamerica.....com/biopharma/stren

Transforming Biopharma with Predictive Modeling and Machine Learning

The biopharma industry sees transformation through prediction modeling alongside machine learning, which speeds up drug discovery and makes clinical trials more manageable and enables personalized treatment delivery. Large database utilization for decision-making enables these technologies to enhance both performance results and financial efficiency while boosting worker output.

https://www.pharmafocuseurope.....com/biopharma/transf

QSAR—Changing the Landscape of Antidiabetic Drug Discovery

In this editorial, the author has analyzed the role of quantitative structure-activity relationship (QSAR) methods in antidiabetic drug discovery. The author has summarized the trends and has suggested the directions in which QSAR research should focus on the design of novel drugs for diabetes.

https://www.pharmafocusasia.co....m/articles/qsar-chan

https://www.pharmafocusamerica.....com/articles/what-a

https://www.pharmafocuseurope.....com/articles/how-qua